Reuters logo
BRIEF-Ortho Dermatologics announces FDA filing acceptance for IDP-118, novel plaque psoriasis treatment
November 2, 2017 / 12:13 PM / 16 days ago

BRIEF-Ortho Dermatologics announces FDA filing acceptance for IDP-118, novel plaque psoriasis treatment

Nov 2 (Reuters) - Valeant Pharmaceuticals International Inc

* Ortho Dermatologics announces U.S. FDA filing acceptance for IDP-118, novel plaque psoriasis treatment

* Valeant - ‍PDUFA date set for June 18, 2018 for IDP-118​‍​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below